Goodrx Holdings earnings were $20.6M for the trailing 12 months ending Mar 31, 2026, with -14.3% growth year over year. The latest GDRX earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.2M, down 78.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GDRX reported annual earnings of $30.4M, with 85.7% growth.
GDRX past earnings growth
How has GDRX's earnings growth performed historically?
What were Goodrx Holdings's earnings last quarter?
On GDRX's earnings call on Invalid Date, Goodrx Holdings (NASDAQ: GDRX) reported Q1 2026 earnings per share (EPS) of $0.00, up 100% year over year. Total GDRX earnings for the quarter were $1.17 million. In the same quarter last year, Goodrx Holdings's earnings per share (EPS) was $0.03.
As of the last Goodrx Holdings earnings report, Goodrx Holdings is currently profitable. Goodrx Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $20.56 million, a 27.75% decrease year over year.
What was GDRX's earnings growth in the past year?
As of Goodrx Holdings's earnings date in Invalid Date, Goodrx Holdings's earnings has grown -14.29% year over year. This is 95.17 percentage points lower than the US Health Information Services industry earnings growth rate of 80.88%. GDRX earnings in the past year totalled $20.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.